United States · FDA National Drug Code directory
fondaparinux sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11797-157_714aaf0c-95ac-4de9-b8d2-5fdcd1365804
- Product NDC
- 11797-157
- Form
- INJECTION, SOLUTION
- Composition / generic term
- fondaparinux sodium
- Labeler
- Italfarmaco S.p.A
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190206
- Source listing expiry
- 20261231
Source-listed ingredients
- FONDAPARINUX SODIUM — 10 mg/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (11797-157-06) / .8 mL in 1 SYRINGE (11797-157-02) · 11797-157-06
- 2 SYRINGE in 1 CARTON (11797-157-09) / .8 mL in 1 SYRINGE (11797-157-02) · 11797-157-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →